“…Significantly, that lineage is circulatory in those regions showing poor or no matching with the local vaccine candidate (Asia1 Shamir) regularly (Jamal et al, ). Similarly, there could be immune pressure due to trivalent vaccination programme using genetically divergent vaccine strain (IND63/72) of serotype Asia1 compared to this novel strain, or inappropriately selected local candidate, which might ultimately favour the generation of this new strain of lineage G‐IX (Ullah et al, ). Moreover, Siddique et al () reported a novel sublineage of serotype O from Bangladesh, and then subsequent works by other contemporary groups detected the same strains across 14 countries, even outside Indian subcontinent zone, from where the strains were reported earlier stage of outbreak and spread (Alam et al, ; Bachanek‐Bankowska et al, ; Zhu et al, ).…”